Pricing

Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

LegalHerald.com comments on details surrounding current Risperdal-related trials filed against defendant Johnson & Johnson. It has been announced that Johnson & Johnson was ordered to pay millions in compensation to Risperdal plaintiffs for trials where juries have reached verdicts. Johnson & Johnson is the parent company of Janssen Pharmaceuticals who manufactures antipsychotic drug Risperdal and who has been facing ongoing legal trouble surrounding the drug over the past few years.

Both Risperdal and Johnson & Johnson were the defendants in cases which resulted in two multimillion-dollar verdicts in February of 2015, one of which was awarded to the family of a young man who alleged he had developed significant gynecomastia while using the drug and another to the state of South Carolina for what was determined to be marketing fraud.

A Philadelphia jury reportedly awarded $2.5 million to the young man who had developed gynecomastia after deciding that the defendant was, in fact, liable for both the boy’s physical and emotional suffering. It was determined that the corporation had failed to adequately warn medical professionals and patients regarding the drug’s possible link to this condition, which causes males to develop significant breast tissue, much like that of females. The young man who was the plaintiff in this case is now age 21, and had begun to take Risperdal at the age of 8 to treat possible autism. Since this time, he grew to develop size 46DD breasts.

Risperdal is a highly potent drug which gained FDA-approval in the early 1990’s. It was approved to treat schizophrenia in adults but was not approved for use in children until much later in 2006. Johnson & Johnson is currently facing allegations that it marketed or pushed “off-label” prescriptions for children well before the drug was FDA-approved for this use.

The attorneys of Banville Law are currently working to help other patients who have taken Risperdal and who believe that it negatively impacted their health. Those affected are deeply encouraged to take advantage of the opportunity to fully evaluate their legal rights in the matter, as they could be entitled to substantial compensation. To better assist those interested in further investigating their options, the attorneys of Banville Law are offering complimentary legal consultations to qualified individuals at this time.

To request further information on Risperdal lawsuits, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About Banville Law :

Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.

Contact Banville Law:

Laurence Banville, Esq.

165 West End Avenue, #1H
New York, NY 10023
United States (US)

888-997-3792

Social Media:

Additional News Releases From Banville Law:

April 29, 2016Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect

April 29, 2016Mother Files Risperdal Lawsuit Claiming Drug Caused Development Of Son’s Gynecomastia

April 29, 2016Risperdal Plaintiff Awarded $1.75 Million In Damages

April 28, 2016Risperdal Lawsuit Plaintiffs Are Awarded $8 Million After The Death Of A Family Member

April 28, 2016Millions Awarded To Plaintiffs In Risperdal Lawsuit Verdicts

April 28, 2016Risperdal Lawsuit Trial Draws Attention To Controversial Testimony And Potentially Hidden Study Results

April 27, 2016Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts

April 27, 2016Louisiana Risperdal Lawsuit Plaintiff Claims Drug Caused Son’s Gynecomastia Development

April 27, 2016U.S. Supreme Court Shows Favor To Risperdal Lawsuit Plaintiffs

April 26, 2016Johnson & Johnson Subsidiary Janssen Pharmaceuticals Loses Third Risperdal Lawsuit